Phase I trial of the poly(ADP-ribose) polymerase (PARP) inhibitor olaparib and AKT inhibitor capivasertib in patients with BRCA1/2 and non-BRCA1/2 mutant cancers
| Image |  |
|---|---|
| Description | scientific article published on 12 June 2020 |
| Author/s |
author: Udai Banerji Susana Miranda Justin Lindemann Shaun A Decordova Yvette Drew Stephen J Pettitt Ruth Matthews Bristi Basu Nina Tunariu Rebecca Kristeleit Ruth Ruddle Karen E Swales Timothy A Yap Emma Hall |
| Publication date | June 12, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |